Author:
Revittser A. V.,Chubinsky-Nadezhdin V. I.,Negulyaev Yu. A.
Reference15 articles.
1. Boldt, J. and Suttner, S.W., Physiology and pathophysiology of the natriuretic peptide system, Yearb. Intensive Care Emerg. Med., 2006, vol. 101–109.
2. Chen, H., Levine, C., Golan, E., Michel, T., and Lin, J., Atrial natriuretic peptide-initiated cGMP pathways regulate vasodilator-stimulated phosphoprotein phosphorylation and angiogenesis in vascular endothelium, J. Biol. Chem., 2008, vol. 283, pp. 4439–4447.
3. Chenxia, H. and Lanjuan, L., Preconditioning influences mesenchymal stem cell properties in vitro and in vivo, J. Cell Mol. Med., 2018, vol. 22, pp. 1428–1442.
4. Daniels, L. and Maisel, A., Natriuretic peptides, J. Am. Col. Cardiol., 2007, vol. 50, pp. 2357–2368.
5. Elferink, J. and Koster, M., Atrial natriuretic factor stimulates migration by human neutrophils, Eur. J. Pharmacol., 1995, vol. 288, pp. 335–340.